Search Results - "Jardi, R."

Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients by Buti, M, Elefsiniotis, I, Jardi, R, Vargas, V, Rodriguez-Frias, F, Schapper, M, Bonovas, S, Esteban, R

“…Background/Aims To determine the factors associated with virological response (VR), HBeAg loss or the emergence of adefovir (ADV)-related mutations in…”
Get full text

HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain by Jardi, R, Crespo, M, Homs, M, Eynde, E, Girones, R, Rodriguez‐Manzano, J, Caballero, A, Buti, M, Esteban, R, Rodriguez‐Frias, F

“…Objectives The aim of the study was to assess the seroprevalence of hepatitis E virus (HEV) infection in an HIV‐infected population, as determined by HEV…”
Get full text

Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference by Jardi, Rosendo, Rodriguez, Francisco, Buti, Maria, Costa, Xose, Cotrina, Montserrat, Galimany, Roman, Esteban, Rafael, Guardia, Jaime

“…The interactions among hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) were studied by measuring HBV-DNA and HCV-RNA levels…”
Get full text

Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long‐term treatment by Tabernero, D., Sánchez, M. J., Homs, M., Rodríguez‐Frías, F., Jardí, R., Schaper, M., Esteban, R., Buti, M.

“…Aliment Pharmacol Ther 2010; 32: 97–104 Summary Background  Some patients continue to have detectable HBV‐DNA levels with liver disease progression after…”
Get full text

Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients by Jardi, R., Rodriguez-Frias, F., Schaper, M., Ruiz, G., Elefsiniotis, I., Esteban, R., Buti, M.

“…It has been suggested that lamivudine therapy can preselect for hepatitis B virus (HBV) variants associated with resistance to entecavir (ETV) treatment. The…”
Get full text

Clinical outcome of lamivudine-resistant chronic hepatitis B patients with compensated cirrhosis under adefovir salvage treatment. Importance of HCC surveillance by Elefsiniotis, I, Buti, M, Jardi, R, Vezali, E, Esteban, R

“…Data concerning the outcome of lamivudine-resistant (LAM-R) chronic hepatitis B (CHB) patients with compensated cirrhosis under adefovir (ADV) treatment are…”
Get full text

Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study by Buti, M., Homs, M., Rodriguez-Frias, F., Funalleras, G., Jardí, R., Sauleda, S., Tabernero, D., Schaper, M., Esteban, R.

“…Long‐term changes in the frequency and outcome of hepatitis delta virus (HDV) infection have seldom been analysed. This retrospective, longitudinal study…”
Get full text

Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection by Rodriguez-Frias, F., Jardi, R., Buti, M., Schaper, M., Hermosilla, E., Valdes, A., Allende, H., Martell, M., Esteban, R., Guardia, J.

“…This study aims to determine the prevalence of hepatitis B virus (HBV) genotypes (A–F) and their association with the G1896A precore mutation in 486 patients…”
Get full text

581 QUANTITATIVE LONGITUDINAL EVALUATION OF HEPATITIS DELTA VIRUS RNA AND HEPATITIS B VIRUS DNA SHOWS A DYNAMIC COMPLEX REPLICATIVE PROFILE IN CHRONIC B/D COINFECTION by Tabernero, D, Schaper, M, Rodríguez-Frías, F, Jardi, R, Homs, M, Ruiz, G, Buti-Ferret, M, Esteban, R

Get full text

561 EFFECT OF ANTIVIRAL TREATMENTS IN EVOLUTION OF HEPATITIS B VIRUS (HBV) CORE REGION EPITOPES by Homs, M, Jardi, R, Buti, M, Tabernero, D, Fernandez-Fernandez, P, Esteban, R, Rodriguez-Frias, F

Get full text

Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay by Jardi, R., Rodriguez, F., Buti, M., Costa, X., Cotrina, M., Valdes, A., Galimany, R., Esteban, R., Guardia, J.

“…A sensitive and accurate HBV DNA quantification assay is essential for monitoring hepatitis B virus (HBV) replication. This study evaluated a real‐time PCR…”
Get full text

Clinical outcome of lamivudine-resistant chronic hepatitis B patients with compensated cirrhosis under adefovir salvage treatment by Elefsiniotis, I, Buti, M, Jardi, R, Vezali, E, Esteban, R

“…Abstract Background Data concerning the outcome of lamivudine-resistant (LAM-R) chronic hepatitis B (CHB) patients with compensated cirrhosis under adefovir…”
Get full text

648 CHANGING PATTERN OF HEPATITIS DELTA VIURS INFECTION IN THE NORTHEAST OF SPAIN (CATALONIA) DURING THE LAST 25 YEARS by Funalleras, G, Homs, M, Buti, M, Schaper, M, Rodriguez-Frias, F, Jardi, R, Esteban, R

Get full text

336 DETECTION OF CLINICALLY RELEVANT MINOR HCV AND HBV ANTIVIRAL-RESISTANT MUTANTS IN TREATMENT-NAIVE PATIENTS USING ULTRA-DEEP PYROSEQUENCING by Rodriguez-Frias, F, Cubero, M, Esteban, J.I, Buti, M, Tabernero, D, Ortega, I, Sanchez, A, Mosquera, J.L, Schaper, M, Homs, M, Garcia-Cehic, D, Sauleda, S, Bes, M, Esteban, R, Jardi, R, Guardia, J, Quer, J

Get full text

Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B by Buti, M., Cotrina, M., Jardi, R., De Castro, E. Cruz, Rodriguez-Frias, F., Sánchez-Avila, F., Esteban, R., Guardia, J.

“…There is no standard therapy for patients with anti‐HBe‐positive chronic hepatitis B. The aims of this study were to analyse the efficacy of lamivudine therapy…”
Get full text

Changes in different regions of hepatitis B virus gene in hepatitis B ‘e’ antigen‐negative patients with chronic hepatitis B: the effect of long‐term lamivudine therapy by Buti, M., Jardi, R., Rodriguez‐Frias, F., Valdes, A., Schaper, M., Esteban, R., Guardia, J.

“…Summary Background : Lamivudine therapy for chronic hepatitis B has been associated with changes in different regions of the hepatitis B virus nucleotide…”
Get full text

Quantitative Hepatitis B Virus DNA Testing for the Early Prediction of the Maintenance of Response during Lamivudine Therapy in Patients with Chronic Hepatitis B by Buti, Maria, Sánchez, Francisco, Cotrina, Montserrat, Jardi, Rosendo, Rodríguez, Francisco, Esteban, Rafael, Guardia, Jaime

“…To determine whether a dramatic decrease in hepatitis B virus (HBV) DNA levels within the first months of lamivudine therapy can predict the emergence of YMDD…”
Get full text

Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults by MIRAVITLLES, M., VILÀ, S., TORRELLA, M., BALCELLS, E., RODRÍGUEZ-FRÍAS, F., ROZA, C.DE LA, JARDÍ, R., VIDAL, R.

“…Severe α1-anti-trypsin (AAT) deficiency implies a high risk of pulmonary emphysema development. The possible relationship between partial deficiencies of this…”
Get full text

Hepatitis E infection in acute sporadic hepatitis in Spain by Jardi, R, Buti, M, Rodriguez-Frias, F, Esteban, R

Get more information

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience by Miravitlles, M., Vidal, R., Barros-Tizón, J.C., Bustamante, A., España, P.P., Casas, F., Martínez, M.T., Escudero, C., Jardi, R.

“…Severe alpha-1-antitrypsin (AAT) deficiency, phenotype Pi ZZ, is a rare condition with an estimated prevalence of 1/4500 individuals in Spain. Given this low…”
Get full text